Marrone Bio Innov (MBII)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,596 | -16,554 | -11,241 | -6,296 | -3,261 |
| Depreciation Amortization | 1,193 | 4,567 | 3,389 | 2,236 | 1,089 |
| Accounts receivable | 1,101 | -3,098 | -2,875 | -4,390 | -3,420 |
| Accounts payable and accrued liabilities | 790 | 585 | 1,105 | -204 | 252 |
| Other Working Capital | -2,732 | -830 | -1,609 | -4,155 | -3,599 |
| Other Operating Activity | -1,152 | 5,369 | 4,660 | 6,546 | 3,922 |
| Operating Cash Flow | $-8,396 | $-9,961 | $-6,571 | $-6,263 | $-5,017 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -198 | -1,093 | -905 | -544 | -119 |
| Other Investing Activity | 0 | -750 | -750 | -750 | -750 |
| Investing Cash Flow | $-198 | $-1,843 | $-1,655 | $-1,294 | $-869 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,430 | 43,340 | 31,839 | 23,584 | 11,504 |
| Debt Repayment | -12,162 | -37,848 | -30,922 | -20,821 | -8,824 |
| Common Stock Issued | 65 | 10,007 | 6,426 | 6,355 | 6,261 |
| Common Stock Repurchased | N/A | N/A | 87 | 63 | 27 |
| Other Financing Activity | 0 | 87 | 0 | 0 | 0 |
| Financing Cash Flow | $-1,667 | $15,586 | $7,430 | $9,181 | $8,968 |
| Beginning Cash Position | 21,183 | 17,401 | 17,401 | 17,401 | 17,401 |
| End Cash Position | 10,922 | 21,183 | 16,605 | 19,025 | 20,483 |
| Net Cash Flow | $-10,261 | $3,782 | $-796 | $1,624 | $3,082 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,396 | -9,961 | -6,571 | -6,263 | -5,017 |
| Capital Expenditure | -198 | -1,093 | -905 | -544 | -119 |
| Free Cash Flow | -8,594 | -11,054 | -7,476 | -6,807 | -5,136 |